Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01615939 · ClinicalTrials.gov registry record · Phase 4
A Study Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block
A Phase 4 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT01615939 is a Phase 4 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 17 participants.
The verdict
NCT01615939, a Phase 4 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the incidence of postoperative symptoms of neurologic injury after a single shot infragluteal-parabiceps sciatic nerve block versus a continuous infragluteal-parabiceps sciatic nerve catheter.
Interventions
- DRUG Bupivacaine
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01615939
The ClinicalTrials.gov registry entry for NCT01615939 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT01615939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01615939 about?
NCT01615939 is a clinical study titled "A Study Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block". The purpose of this study is to compare the incidence of postoperative symptoms of neurologic injury after a single shot infragluteal-parabiceps sciatic nerve block versus a continuous infragluteal-parabiceps sciatic nerve catheter.
What is the current status of trial NCT01615939?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2012-06. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01615939?
The interventions under investigation include: Bupivacaine (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT01615939?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.